Arda CEO Adam Freund and CTO Rémi Laberge on Translating aging podcast

Arda’s founders, CEO Adam Freund and CTO Rémi Laberge joined the Translating Aging podcast with host Chris Patil to explore Arda’s cutting-edge approach to treating chronic diseases. Adam and Remi discussed Arda’s origin and shared how the company’s single-cell-based discovery platform pinpoints pathogenic cells in conditions like fibrosis, allowing for targeted cell depletion instead of traditional pathway modification. They described the challenges and opportunities inherent to applying the immune-oncology toolbox to non-oncology diseases, and outlined their vision for antibody-based therapeutics that could offer long-lasting effects with intermittent dosing, improving patient quality of life and paving the way for future applications in aging.